A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Efficacy and Safety of Lesinurad and Allopurinol Compared to Allopurinol Alone in Subjects with Gout who have had an Inadequate Hypouricemic Response to Standard of Care Allopurinol.

Register Today!

Trial Information

Trial Duration24 weeks
Number of Visits10
Lead CRCTherese Vaillancourt

For additional information
on this trial contact: